Georgia State University

ScholarWorks @ Georgia State University
Respiratory Therapy Theses

Department of Respiratory Therapy

Spring 4-4-2017

Prediction Equations for Pulmonary Diffusing Capacity for Nitric
Oxide in Healthy African-American Adults
Ahmad Almamary

Follow this and additional works at: https://scholarworks.gsu.edu/rt_theses

Recommended Citation
Almamary, Ahmad, "Prediction Equations for Pulmonary Diffusing Capacity for Nitric Oxide in Healthy
African-American Adults." Thesis, Georgia State University, 2017.
doi: https://doi.org/10.57709/10099697

This Thesis is brought to you for free and open access by the Department of Respiratory Therapy at ScholarWorks
@ Georgia State University. It has been accepted for inclusion in Respiratory Therapy Theses by an authorized
administrator of ScholarWorks @ Georgia State University. For more information, please contact
scholarworks@gsu.edu.

ACCEPTANCE

This thesis, A PREDICTION EQUATION FOR PULMONARY DIFFUSING CAPACITY FOR
NITRIC OXIDE IN HEALTHY AFRICAN-AMERICAN ADULTS, by Ahmad Saleh Almamary
was prepared under the direction of the Master’s Thesis Advisory Committee in the Department
of Respiratory Therapy at Georgia State University. It is accepted by the committee in partial
fulfillment of requirements for the Masters of Science degree in Respiratory Therapy at Byrdine
F. Lewis School of Nursing and Health Professions at Georgia State University. The Master’s
Thesis Advisory Committee, as representatives of the faculty, certifies that this thesis has met all
standards of excellence and scholarship as determined by the faculty.

___________________________ Date _______________
Gerald S. Zavorsky, PhD, CSCS, ACSM-RCEP, RPFT, FACSM
Committee Chair

___________________________ Date _______________
Douglas S. Gardenhire, EdD, RRT-NPS, FAARC
Committee Member

___________________________ Date _______________
Shi Huh Samuel Shan, MS, RRT-NPS-ACCS
Committee Member

AUTHOR’S STATEMENT
In presenting this thesis as partial fulfillment of the requirements for the master degree from
Georgia State University, I agree that the library of Georgia state university shall make it
available for inspection and circulation in accordance with the regulations governing materials of
this type. I agree that permission to quote, to copy from, or to publish this thesis may be granted
by the professor under whose direction it was written, by the Byrdine F. Lewis School of
Nursing and Health Professions director of graduate studies and research, or by me. Such
quoting, copying, or publishing must be solely for scholarly purpose and will not involve
potential financial gain. It is understood that any copying from publication of this thesis, which
involves potential gain, will not be allowed without my written permission.

Author
Ahmad Saleh Almamary

NOTICE TO BORROWERS
All these deposited in the Georgia State University Library must be used in accordance with
Stipulations prescribed by the author in the preceding statement. The author of this thesis is:
Ahmad Saleh Almamary

The director of this thesis is:
Gerald S. Zavorsky, PhD, CSCS, ACSM-RCEP, RPFT, FACSM
Associate Professor
Byrdine F. Lewis School of Nursing and Health Professions
Department of Respiratory Therapy
Georgia State University
P.O. Box 4019
Atlanta, GA 30302-4019
Users of this thesis not regularly enrolled as students of Georgia State University are required
to attest acceptance of the preceding stipulation by signing below. Libraries borrowing this
thesis for use of their patrons are required to see that each user records here the information
requested:

NAME OF USER

ADDRESS

DATE TYPE OF USE
(EXAMINATION ONLY OR COPYING).

DEDICATION
In the beginning, I thank God for all the blessing during the completion of this thesis and
throughout my life. I dedicate this thesis to the two people who always motivated me and guided
me through my whole life who made me be the man who I am today. My father is the first man
that I always go to whenever I want any advice, motivation, and guidance. And my lovely
mother, mom, you are the only person who I go to whenever I feel down, and when I talk to you,
you gave me the strength and motivation to overcome difficulties that I face in my life. Father
and mother, there is no words that will express my gratitude, and I wish you health and
happiness forever. Thank you very much, my father and mother.
To my family and friends for their support and encouragement especially my brothers
and sisters for their unlimited care, love, and confidence. You always got my back and took care
of my parents during their health and sickness while I am studying abroad in the United States.
To my professor, Dr. Gerald S Zavorsky for his unlimited patience, guidance, and
motivation. Dr. Z you are my professor, supervisor, friend, and mentor who always being willing
to help, motivate, and support me through my thesis. I gained a lot of skills, experiences, and
knowledge while I worked on my thesis with you. You represent the idealistic meaning of a
professor and a great role model. Thank you from my bottom of my heart.

ACKNOWLEDGMENTS
I would like to thank the Jerome M. Sullivan Research Fund from the American
Respiratory Care Foundation (ARCF) for funding this research. Also, I want to thank the
Chair and Clinical Associate Professor of the Department of Respiratory Therapy, Dr.
Douglas S. Gardenhire for his support and guidance. Also, I would like to thank
Professor Shi Huh Samuel Shan for sharing his insight, and his time to help me
throughout my thesis. Also, I would like to thank all my supportive friends here in
Atlanta especially at Georgia State University for being cheering, and motivating me
through my thesis. Also, I want to give special thanks to my brother from another mother
Abdullah Nasser Alharthi for being a great friend, colleague, and roommate for all his
advices, insights, and encouragements throughout all the time while I lived with him.

Ahmad Saleh Almamary
Spring 2016

Prediction equations for pulmonary diffusing capacity for nitric oxide in healthy AfricanAmerican Adults

By
Ahmad Saleh Almamary
A Thesis
Presented in Partial Fulfillment of Requirements for the
Degree of
Master of Science
In
Health Sciences
In
The Department of Respiratory Therapy
Under the supervision
Of
Dr. Gerald S. Zavorsky
In
Byrdine F. Lewis School of Nursing and Health Professions
Georgia State University
Atlanta, Georgia
2017

ABSTRACT

Pulmonary diffusing capacity for nitric oxide (DLNO) is a relatively new pulmonary
function test to assess gas transfer in the lung. To date, there are no prediction equations made
for healthy adult African-American (black) subjects. Thus, the purpose of this study was to
create prediction equations for DLNO in this ethnic/racial group. A total of 59 healthy subjects
(27 males and 32 females) were recruited to perform pulmonary function testing at Georgia State
University. They were diverse in age (18-67 yr), height (140-189 cm), and body mass index
(17.2-32.3 kg/m2). All subjects completed single-breath maneuvers at rest inhaling 43 ± 4 ppm
NO with a standard diffusion mixture. The breath-hold duration was 5.6 ± 0.6 s. Multiple linear
regression predicted DLNO based on the subject’s age, height, and sex. The prediction equation
for DLNO (mL/min/mmHg) = 0.92·(height in cm) +38.8·(sex) – 0.012·(age2) – 25, where 1 =
male, 0 = female for sex. About 77% of the variance in DLNO was accounted for by sex (67%),
age2 (7%), and height (4%). The standard error of the estimate in predicting DLNO was 16.3
mL/min/mmHg. Those with higher resting heart rates had a lower DLNO (r =-0.28, p = 0.03) but
it was not included in the regression model as it did not enhance the fit. Black males had a 7-10%
lower DLNO and black females had a 12-15% lower DLNO compared to matched white
subjects. Black males of the same age and height had a 10% smaller alveolar volume, while
black females had a 15% lower alveolar volume compared to matched white subjects. In
conclusion, DLNO values and alveolar volumes are reduced in blacks compared to matched
whites. The regression model presented best predicts DLNO in African-Americans below 40
years of age.
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CHAPTER I
INTRODUCTION
Pulmonary function tests (PFTs) are essential tools in today’s routine clinical assessment of
respiratory function. They are used in the evaluation of patients with respiratory symptoms and
for guiding the management of diagnosed lung disease. Without the guidance of PFTs, large
number of patients get misdiagnosed and improperly treated. One such pulmonary function test,
otherwise known as pulmonary diffusing capacity for carbon monoxide (DLCO), was established
in 1957 [1]. Since 1957, the single-breath DLCO test has become the clinical standard to assess
gas transfer through the alveolar-capillary membrane. Historically, prediction equations have
been made for DLCO, but not DLNO. Prediction equations are necessary for deciphering
between normal and abnormal gas transfer through the lung and is usually based on the sex,
height, and age, and sometimes the racial backgound of the subject. These equations have been
created for adults [2-7] and children [8, 9], with a wide range of racial backgrounds [10-17].
Two abstracts were published in the early 1980’s examining the use of nitric oxide as a
transfer gas through the alveolar-capillary membrane [18, 19]. These abstracts resulted in the
first publications of DLNO in the late 1980s [20, 21]. Since, then several studies have been
published demonstrating its superiority compared to the DLCO test. The chief barrier to CO
uptake (~70-80%) resides within the red cell while ~25% is located in the alveolar membrane
(See Figure 1 elsewhere [22]). The main advantage of using NO as a transfer gas is that the main
barrier for NO uptake resides between the alveolar and red blood cell membranes (~60%) [23].
This advantage gives DLNO a better representation of gas transfer through the alveolar-capillary
membrane compared to DLCO. Unlike DLCO, the DLNO is unaffected by changes in
hemoglobin concentration [24], carboxyhemoglobin concentration [25], alveolar oxygen pressure
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(PAO2) or inspired oxugen concentration [26, 27]. DLNO is more affected by lung volume
compared to the DLCO which makes the KNO (mathematically, DLNO divided by alveolar
volume) a better measure than the KCO (mathematically, DLCO divided by alveolar volume) in
those with restrictive lung disease [22]. Finally, the sensitivity in detecting cardipulmonary
disease is better using DLNO compared to DLCO [28]. These examples demonstarate there is
evidence that the DLNO test is techinically and physiologically superior than the DLCO test
[28].
To date there has been few prediction equations developed for single-breath DLNO in
adults [29-32] and children [33, 34]. One study has combined data from three studies to create a
more accruate prediction model on nearly 500 white subjects [22]. However, no prediction
equations for DLNO have been developed in the African-American population (herein known as
the black population).
There are ethnic/racial differences in certain aspects of lung function. For example, 15%
of the variability in vital capacity is accounted for by race/ethnicity [35]. In a black population,
vital capacity (i.e. lung volume) is about 15% lower in blacks compared to age, height, and sex
matched whites [11, 36], and the DLCO is also lower in blacks compared to matched whites [11,
17]. Specifically, DLCO is lower by ~2 (~6%) and ~5 (~15%) mL/min/mmHg in black, age and
height matched males compared to matched white females, respectively [17]. Thus the difference
in DLCO between blacks and whites stem from differences in alveolar volume and hemoglobin
concentration as there is a ~6% larger hemoglobin concentration in whites compared to blacks
[17]. Even though DLNO is minimally affected by hemoglobin concentration [24], the
development of DLNO prediction equations for blacks do seem warrented since there are large
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differences in lung volumes between the two difference ethnic/racial groups. This thesis
examines DLNO in the younger, adult black population of Atlanta, GA.

Statement of the Problem
Age, sex, height, and ethnicity/race predict several lung function variables. Height is the greatest
predictor of lung volume since about 60% of the variance in vital capacity is shared by height
[29]. Sex also contributes to a difference in lung volumes as women have about 600 mL lower
alveolar volume (VA) compared to height and age matched males [29]. Moreover, as mentioned
previously, there are also ethnic/racial differences in lung volumes [36] and DLCO [11, 17]. The
reasons for differences in lung volumes between white and blacks are complex, because race is a
social as well as a biological construct [37]. Even after adjusting for anthropometric,
socioeconomic, and nutritional variables, there remains a large unexplained portion of the
differences in vital capacity between blacks and whites [37].
As there are no prediction equations developed for DLNO in blacks, the development of
these prediction equations is warranted given the ethnic/racial differences in DLCO. Imagine if a
prediction equation for diffusing capacity for whites was used in a black population. There could
be a misdiagnosis of a pathophysiology in the black population since more blacks would be
below the lower limit of normal for diffusing capacity due to their lower alveolar volumes
compared to the white population. Thus, a black individual with normal diffusing capacity
would be misdiagnosed due to the use of an incorrect prediction equation meant for whites.
That’s why ethnic/racial specific equations should be made for DLNO. Furthermore, a 2017
European Respiratory Society (ERS) Task Force document suggests that reference values are
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lacking in non-white populations and should be pursued [22]. Thus, the major goal of this study
was to develop prediction equations for DLNO in a black population.

Purpose of the study
The purpose of this study is to develop prediction equations for DLNO and KNO in the black
population. Prediction equations for DLNO in the black population are essential so that there is
a reduced chance for misdiagnosis of lung disease.

Research questions
1. What is the prediction equation for both DLNO and KNO in a relatively healthy black
population living in Atlanta, GA?
2. What is the percent difference in DLNO and VA between blacks and whites matched for
age, height, and sex?

Significance of the Study
Prediction equations have been developed for all sorts of lung function tests. These equations are
necessary to guide pulmonologists in the diagnosis and management of lung disease, so that their
interpretation of a patient’s lung function can be made more accurately. The “predicted” value
of a certain lung function test for a patient’s age, height, sex, and race are compared against the
patient’s measured value. Creation of such race specific equations will allow for better accuracy
in determining lung disease, and these values will assist the pulmonologist to formulate the
proper care plan. By understanding what the lower limit of normal (LLN) is for DLNO for a
black person of given height, age, and sex, we can understand what are the values below which a
pathophysiology exists in the group so as to promote better lung health in this population. If
abnormal, then appropriate treatment can be determined. Thus, the development of prediction
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equations for DLNO and KCO in African-Americans are essential to provide accurate predicted
values.

Definitions of words or terms
ATS – American Thoracic Society
CO – Carbon Monoxide
ΘCO – specific conductance in the blood for CO [mL CO · (mL blood/min/mmHg)]
COHb – carboxyhemoglobin
COPD - Chronic Obstructive Pulmonary Disease
DL – Diffusing Capacity of the Lung
DLCO – Diffusing Capacity of the lung for carbon monoxide (mL/min/mmHg)
DLNO – Diffusing Capacity of the lung for nitric oxide (mL/min/mmHg)
DMCO – Alveolar-capillary membrane diffusing capacity for CO
ERS – European Respiratory Society
FEV1 – Forced expiratory volume in 1 second
FVC – Forced vital capacity
FRC – Functional residual capacity
GSU – Georgia State University
Hb – Hemoglobin
KCO – Logarithmic change in CO concentration per unit time and unit pressure (mL
STPD/min/mmHg/L) and mathematically equivalent to DLCO divided by alveolar
volume
NO – Nitric Oxide
ΘNO – Specific conductance in the blood for NO [mL NO · (mL blood/min/mmHg)]
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KNO – Logarithmic change in NO concentration per unit time and unit pressure mL
STPD/min/mmHg/L and mathematically equivalent to DLNO divided by alveolar
volume
LLN – Lower limit of normal, taken as the 2.5th percentile
PFTs – Pulmonary Function Tests
VA – Alveolar volume (L)
Vc – Pulmonary capillary blood volume (mL)
TLC – Total lung capacity (L)
ULN – Upper limit of normal, taken as the 97.5th percentile

Assumptions
It was assumed that at least 100 healthy black male and female subjects from the Atlanta, GA
area can be recruited. The subjects will vary age, sex and height. It is also assumed that each
subject will give their best effort during the tests. Furthermore, it was assumed that each subject
was truthful in reporting that they were healthy non-smokers with no symptoms of
cardiopulmonary disease. Finally, it was assumed that the equipment used to measure DLNO is
functioning adequately.

Limitations
The study findings might be affected due to the geographical location of the data collection. The
data was collected at one location, Georgia State University (GSU), in Atlanta, GA, and that
could be a limitation to the study as the results may not be representative of the entire population
of African-Americans. It was also difficult to recruit older subjects (>50 years old) as most of
the subjects that attend GSU are younger (< 29 years old).
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CHAPTER II
REVIEW OF THE LITERATURE
The diffusing capacity of the lung (DL) is the measure of the flow of inhaled gas from the
alveoli to the blood per unit difference in pressure. The total DL is made up of two conductances:
the diffusing capacity of the alveolar-capillary membrane (DM) and the pulmonary capillary
volume (Vc) multiplied the specific conductance in the blood for CO (ΘCO). Roughton and
Forster (1957) demonstrated that the resistance to total oxygen diffusion derived from two
resistances in series: membrane resistance and red cell resistance such that 1/DLCO = 1/DMCO
+ 1/(ΘCO·Vc) where DLCO is the pulmonary diffusing capacity for carbon monoxide in
mL/min/mmHg, DMCO is the alveolar-capillary membrane diffusing capacity for CO in
mL/min/mmHg, ΘCO is specific conductance in the blood for CO in mL CO·(mL
blood/min/mmHg), and Vc is the pulmonary capillary blood volume in mL [38].
In order to obtain DMCO and Vc, a subject inspires a diffusion mixture at two different
oxygen concentrations and then plot the 1/DLCO results on a graph. For example, the first
mixture would be 0.3% CO, 21% O2, 10% He, balance N2, and the subject would calculate
DLCO from that inspired mixture. Then the subject would perform another test where he/she
would inspire a second mixture containing 0.3% CO, 60% O2, 10% He, Balance N2 and the
subject would calculate DLCO from that mixture. Then the results are plotted: The y-axis would
be the inverse of DLCO (1/DLCO), and the x-axis would be 1/ΘCO for each mixture. The slope
of the two points would be 1/Vc and the y-intercept would be 1/DMCO. Then the inverse of
1/DMCO and 1/Vc would be the DMCO and Vc, respectively.
As one can see, calculating DMCO and Vc takes time. One would need at least two tests
at the 21% O2 concentration to obtain an average DLCO at that concentration, then another two
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tests at the 60% O2 concentration to obtain an average at that concentration. Thus, these 4 tests
would take about 16 minutes of time and there would be a small build-up of CO in the blood.
However, in the 1980’s, researchers determined that by inhaling a small amount of NO
together with CO in a single-breath maneuver, one could obtain DLCO and pulmonary diffusing
capacity for nitric oxide (DLNO) in a single-maneuver, and then interpolate DMCO and Vc from
that one maneuver [20]. Since that discovery in the 1980’s, there has been much debate on
whether DMCO and Vc could be determined from this modified Roughton-Forster technique as
there are a lot of considerations that need addressing [39, 40]. Nevertheless, the latest DLNO
standardization document published in 2017 has said that it is possible to obtain DMCO and Vc
using modified Roughton-Forster technique [22].
One important fact about DLNO is that unlike the DLCO, the main barrier for NO resides
between the alveolar and red blood cell membranes [23]. Thus, DLNO better represents gas
transfer through the alveolar-capillary membrane compared to DLCO. This is evident in Figure 1
of a recent ERS Task Force document on DLNO that demonstrates that only ~25% of the
resistance to CO diffusion is located in the alveolar-capillary membrane, while ~60% of the
resistance NO diffusion is located in the alveolar-capillary membrane [22]. Since DLNO is a
better index of gas transfer though the alveolar-capillary membrane compared to DLCO, a
measurement of DLNO should be technically superior compared to DLCO in evaluating
pulmonary disease.
DLNO is considered to be a better test compared to the DLCO for several reasons. The
first reason is DLNO is unlike the DLCO, it is a better represents gas transfer through the
alveolar capillary membrane[22]. Also, unlike the DLCO, the DLNO is unaffected by the
subject’s hemoglobin concentration [24], carboxyhemoglobin concentration [25] and partial
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pressure of inspired oxygen (PO2) [26, 41]. However, DLNO is more affected by lung volumes
changes compared to DLCO [22], thus the DLNO test would be better to examine restrictive
lung disease that the DLCO test. There is also evidence to support that DLNO has better
sensitivity to detect cardiopulmonary disease compared to DLCO [28], and as such, it is about
time that clinicians use this test routinely [42, 43].
Nevertheless, in order for DLNO to gain use worldwide, prediction equations need to be
created. With the DLCO, predictions have been created been created for adults [2-7] and
children [8, 9], and over a wide range of racial backgrounds [10-17], no such racially-adjusted
equation has been developed for DLNO. To date there has been few prediction equations
developed for single-breath DLNO in adults [29-32] and children [33, 34]. A recent ERS Task
Force combined data from three studies to create a more accruate model on nearly 500 white
subjects rangfing from 18 to 93 years old [22]. However, there are no studies to date that has
created prediction equations for DLNO in the black population. The main goal of this study is to
develop prediction equations for DLNO in the black population.
Table 1 shows the few studies on prediction equations for DLNO in adults and children.
Nearly all subjects in these studies were performed on the white population from Europe or in
Canada. All studies in Table 1 use a combination of age, height and sex in their models to
predict DLNO. As Table 1 shows, the models have a relatively good fit in predicting DLNO
from height, age and sex. That is ~70% of the variance in DLNO can be predicted by the models
in Table 1.
Van der lee et al. (2007) carried out a study to develop reference DLNO [30]. The
authors selected healthy volunteers from local hospital staff. The inclusion criteria included
negative history of smoking, no complaints related to respiratory system and negative history
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about use of any medication. Individuals with serious respiratory or chronic illnesses such as
diabetes mellitus were excluded. The study enrolled 124 individuals (59 females and 65 males)
who were undergone plethysmography to determine static and dynamic blood volumes. The
authors concluded that DLNO is most closely related to membrane diffusion capacity thus
indicating preferential use of DLNO over DLCO. Aguilaniu et al. (2008) calculated reference
values for transfer of NO and CO in two European cities; Grenoble (300-m altitude) and
Bordeaux (30 m altitude) [31]. In the present study 303 individuals were recruited in the range of
18 to 94 years who underwent single breath technique to measure true diffusion capacity,
pulmonary capillary blood volume and diffusion capacity for CO and NO. The authors
concluded that the diffusion capacity was affected by age, sex, height and where the test was
carried out. Zavorsky et al. (2008) attempted to develop reference values for DLNO in adult
white population. The study sample comprised of 130 (66 males and 64 females) individuals
from young to old age who performed single breath holding maneuvers for a duration of 5
seconds [29]. Only 20 of these subjects (15%) were ≥ 60 years old. All subjects were subjected
to spirometry before participation in the study and 96% of them did not have any signs of
pulmonary disease a displayed by spirometry. They showed that DLNO was 5x larger than the
DLCO, with height, sex, and age as significant predictors of DLNO (adjusted R2 = 0.70). If
alveolar volume was used instead of height, the model had a higher adjusted R2.
The most comprehensive model for predicting DLNO was developed using nearly 500
white subjects ranging from 18 to 93 years old [22]. It was a model based on data from three
previous studies [29-31]. Height explained 45% of the model, followed by age2 (13%), followed
by sex (11%). The full model accounted for 69% of the variance in DLNO. The LLN (2.5th
percentile) and ULN (97.5th percentile) was developed and presented as an on-line supplement
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[22]. The model demonstrates that the LLN and ULN for DLNO are ± 39.2 mL/min/mmHg
below and above the predicted values, respectively [22]. For DLCO, the LLN and ULN for were
± 8.2 mL/min/mmHg below and above the predicted values, respectively [22].
While it is recommended that a 10 seconds breath-hold time for DLNO tests be used for
better gas mixing [22], a 4-6 seconds breath-hold time can be acceptable if using a less sensitive
NO electrochemical cell [22]. In the comprehensive prediction model for DLNO [22], the breathhold time was ~6 seconds, and the inspired oxygen and NO concentration was 19.5% (SD 0.7%),
and 35 (12) ppm, respectively [22].
In Table 2, the prediction equations for DLCO are presented for comparison to DLNO.
Table 2 demonstrates that DLNO and DLCO follow each other closely. There is an approximate
90% shared variance between DLNO and DLCO [22], with the DLNO being 4.6 to 4.8x larger
than the DLCO in healthy white subjects [22]. In subjects with various cardiopulmonary
diseases, the percentage shared variance between DLNO and DLCO drops to 62% [28].
Furthermore, when there is a mean reduction in DLCO compared to healthy controls, DLNO is
reduced similarly [28]. Finally, DLNO is more affected by lung volume changes than the DLCO.
For a 50% reduction is alveolar volume, DLCO is only reduced by ~25%, while, DLNO is
reduced by ~40% [22]. These results suggest, DLNO is a better indicator of gas transfer in those
with restrictive lung disease.
Vital capacity (i.e. lung volume) is about 15% lower in blacks compared to age, height,
and sex matched whites [11, 36]. The DLCO is also lower in matched whites [11, 17]. These
predictors demonstate the need for racial specific equations for DLNO. Studies demonstrate that
DLCO is lower by ~2 (~6%) and ~5 (~15%) mL/min/mmHg in black, age and height matched
males compared to matched white females, respectively [17]. Thus the difference between blacks
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and whites is mostly from lung volume differences, but also from hemoglobin differences as
there is a ~6% larger hemoglobin concentration in whites compared to blacks [17]. Previous
work has shown that DLNO is minimally affected by hemoglobin concentration [24], so the
hemoglobin differences between blacks and whites should be inconsequential in the development
of DLNO prediction equations for blacks. However, DLNO prediction equations are warrented
since lung volume differences must be accounted for between the two ethnic/racial groups.
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CHAPTER III
METHODOLOGY
Healthy black male and female non-smoking adults from Georgia State University (GSU) were
recruited by word of mouth and through the posting of flyers to participate in one testing session
involving the measurement of various lung parameters including DLNO and DLCO at the Petit
Science Center (room 457) at GSU. This study was performed in conjunction with another study
examining the six-minute walk test in this same ethnic/racial group and was approved by the
Georgia State University ethics board (IRB #H16120, Reference # 335588). The inclusion and
exclusion criteria was as follows:

Inclusion criteria:


Apparently healthy, black, non-smoking and non-pregnant individuals’ ≥ 18 years of age,
with a body mass index (BMI) ranging from 17.0 to 34.9 kg/m2. Non-smoking will be
defined as never smoked or quit smoking > 6 months previously.



These subjects did not have cardiopulmonary disease or they will be absent of major
signs/symptoms suggestive of cardiopulmonary disease [44].

Exclusion criteria:


Individuals who were less than 18 years of age, who are not black, or have a BMI < 17.0
or ≥ 35.0 kg/m2, or are currently smoking or ceased smoking within the previous six
months, or who are pregnant.



Have cardiopulmonary disease, or presence of major signs/symptoms suggestive of
cardiopulmonary disease [44],



Have chest or abdominal pain or any cause, oral or facial pain exacerbated by a
mouthpiece, stress incontinence, dementia or in a state of confusion [45].
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Procedures
The study was conducted at Room 457 of the Petit Science Center and the procedures lasted
approximately 1.75 hours per subject. Subjects signed an informed consent form to participate in
the study. Subjects filled out a questionnaire about their date of birth, sex, as well as physical
activity readiness questionnaire (PAR-Q) and a health questionnaire. Then height, weight, waist
and hip circumference was measured. After those parameters were obtained, heart rate was
measured via a POLAR A300 heart rate monitor (Polar Electro Oy, Kempele, Finland) during
the pulmonary function tests. The average heart rate recorded during these lung function tests
(i.e. 20-30 minutes) was used for data analyses.
Several pulmonary function tests were performed: spirometry, slow vital capacity, total
lung capacity, pulmonary diffusing capacity, maximal inspiratory (MIP) and expiratory pressures
(MEP). The procedures, rules, and established safety for conducting these lung function test are
described elsewhere [46-50]. The diffusing capacity test involved subjects inspiring about 4 to 6
liters of a standard diffusion gas mixture that is used for diagnostic purposes including a small
amount of NO (i.e. 0.3% CO, 21% O2, 10% He, 40-60 ppm NO, Balance N2). This gas is inhaled
once for 5 to 10 seconds at total lung capacity, and then exhaled.
The Hyp’Air discrete lung diffusion system (Medisoft Inc., Dinant, Belgium) was used
for the assessment of DLNO and DLCO using the 5 second breath-hold maneuver. The Medisoft
/ Morgan Scientific Bodybox (Plethsymograph, model 5550) was used for the assessment of
spirometry, TLC, and DLCO using the 10 s breath-hold maneuver. The best values for
spirometry were reported [46], and the mean value for DLNO and DLCO was reported when the
two highest DLCO values varied by not more than 3 mL/min/mmHg and the two highest DLNO
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values did not vary by more than 17 mL/min/mmHg [22]. For the measurement of TLC from the
body box, three values for FRC that agreed within 5% was obtained, and the mean reported [48].
All data were manually recorded on specially formatted collection sheets which was
stored at a secure location in PSC 457. This lab was locked with access granted only to the
faculty advisor and student researchers. Electronic backup of information was provided by the
investigators on excel spreadsheets on password protected computers, locked inside PSC 457.
Subjects were paid $30 for their participation. The funding for this study came from the Jerome
M. Sullivan Research Fund from the American Respiratory Care Foundation.

Calculation of DLNO, DLCO, DMCO, and Vc
The DLNO and DLCO was calculated using the recommended guidelines from the ATS and
ERS [22, 51]. The DMCO and Vc were estimated by using the ΘCO formula from Guénard and
colleagues [27], the ΘNO of 4.5 mL NO·(mL blood/min/mmHg) from Carlson and Comroe [52],
the DMNO/DMCO ratio of 1.97, a standardized women’s hemoglobin concentration of 13.4
g/dL, a standardized men’s hemoglobin concentration of 14.6 g/dL, and a PAO2 of 100 mmHg, as
recommended by the ERS Task Force [22].

Statistical analyses
Spirometry values (FVC, FEV1, FEV1/FVC ratio) was compared to predicted values for the
black population [36]. Total lung capacity was compared to the predicted values for a white
population [3]. The mean predicted values were compared to the mean measured values via a
paired t-test. In prediction studies, the number of subjects should be sufficiently large because
the larger the sample, the more likely it will be to represent the population. It is known that there
is a direct relationship between the correlation and the ratio of the number of variables in the
model (k) to the number of participants in the model (n), such that (k – 1) ÷ (n – 1) [53]. Thus, if
15

a study has 40 participants and 30 variables, the R2 would be 0.74 based on chance alone and the
results would be meaningless. Thus, it is recommended that there be at least a 10:1 participant to
variable ratio to avoid this error [53]. Furthermore, another formula used: n ≥ 50 +8·k also
predicts the number of subjects needed to develop a reliable equation [54]. So in this case, where
there are five potential predictors for DLNO (age, age2, the interaction term age·age2, sex,
weight, height), at least 60 to 98 subjects would be needed.

A multiple linear regression using the stepwise procedure was conducted to determine
which independent variable DLNO (age, age2, the interaction term age·age2, sex, weight, height)
were predictors of DLNO (first dependent variable), KNO, (second dependent variable) and
alveolar volume (third main dependent variable). Since regression is very sensitive to extreme
cases, outliers were removed. Any data point that exceeded the chi-square criteria (standard
deviation of the residuals > 3.0) was eliminated. Then, linearity was analyzed by creating a
scatterplot matrix of the variables age, age2, DLNO, KNO, weight, and height. Another plot was
created between the standardized residuals (y-axis) and standardized predicts (x-axis) to see if
the values will be consistently spread out, which would indicate normality and homoscedasticity.
The lower limit of normal (LLN) will be calculated by multiplying the standard error of the
estimate by 2.0 and then subtracting that number from the prediction1. This value would
represent the 2.5th percentile according to t-tables. Any patient that has a value below LLN was
considered a true pathophysiological abnormality in diffusing capacity. The upper limit of
normal (ULN) was calculated by multiplying the standard error of the estimate by 2.0 and adding
it to the prediction1. This value would represent the 97.5th percentile according to t-tables. Any
patient that has a value above the ULN would indicate a clinically meaningful increase in

1

When the Degrees of Freedom is 60, the z-score is not ± 1.96 for the 2.5th and 97.5th percentiles, it is ± 2.00.
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diffusing capacity above predicted, which signifies genetically superior alveolar-capillary
membrane diffusion capability. A Type I probability level of 0.05 will be used. Statistical
software utilized for this project will be IBM SPSS Statistics Version 21.0, Chicago, IL.
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CHAPTER IV
RESULTS
Fifty-nine adult black subjects were recruited from GSU over a period of six months in 2016
(Table 3). All the fifty-nine subjects (32 females, 27 males) completed all tests. The subjects
ranged from 18 to 67 years of age and the mean resting heart rate was 80 (SD 10) beats/min.
The breakdown of the age categories was as follows: 18 to 29 years old (17 males and 18
females), 30 to 39 years old (7 males and 4 females), 40 to 49 years old (2 males and 7 females),
50 to 59 years old (1 male and 1 female), 60-69 years old (0 male and 2 females) with a BMI
ranging from 17 to 32 kg/m2. Only 22% of the subjects were ≥ 40 years old. All the subjects
claimed to be healthy with no previous cardiac or pulmonary issues. Most subjects had normal
spirometric function for their race. However, five subjects (8%) of the subjects did have mild
obstructive issues as determined by the FEV1/FVC being below the LLN (Table 4).
The DLNO using the five second breath-hold (DLNO5s) ranged from 71 to 205
mL/min/mmHg (Table 5). The DLCO using the five second breath-hold (DLCO5s) and 10
second breath-hold (DLCO10s) were similar and ranged from about 16 to 45 mL/min/mmHg
(Table 5). The inspired NO and oxygen concentration from the DLNO5s was 43 (4) ppm, and
19.7 (0.12) %, respectively (Table 6). The mean DLCO5s values were not statistically different
compared to the mean DLCO10s values (Table 7); although VA was statistically larger, by 150
mL (3%) in the DLCO5s test (Table 7). The DLNO5s was about 5x larger than the DLCO5s (Table
2).
Prediction equations for DLNO and the components of DLCO are presented in Table 8.
About 77% of the variance in DLNO was accounted for by sex (67%), age2 (7%), and height
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(4%). Interestingly, both DLNO and DLCO negatively correlated with resting heart rate (Figure
1), but the heart rate was not included in any of the models due to its poor predictive value.
As expected, the prediction equations in the black population (Table 8) yielded lower
predicted DLNO, KNO and VA compared to the ERS prediction equations [22]. When compared
to whites of the same age and height, black males had a 7-10% lower DLNO, and black females
had a 12-15% lower DLNO (Table 9). Black males of the same age and height had a 10%
smaller alveolar volume, while black females had a 15% lower alveolar volume compared to
matched whites (Table 9).
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CHAPTER V
DISCUSSION
The purpose of this study was to develop prediction equations for DLNO and KNO in healthy
adult black subjects. The development of prediction equations in this ethnic/racial group was a
response to a recent ERS Task Force document citing its need [22]. To date, there are no
published papers on prediction equations for DLNO in this ethnic/racial group. These are the
first predictions equations ever developed for the black population.
Overall, data collection was performed adequately. Mean inspired volumes were 94% of
the FVC during the DLCO10s and 89% of the FVC for the DLNO5s test. The mean VA measured
from DLCO10s and DLCO5s was 91% and 88% of the measured TLC from the Bodybox,
respectively.
The data demonstrates that black males have a DLNO5s that is 34 mL/min/mmHg higher
than black females. This is a similar difference between the sexes in white subjects [22]. For
every one cm increase in height, DLNO5s increases similarly in the white (0.8 mL/min/mmHg
per cm) [22] and black population (0.9 mL/min/mmHg per cm) (Table 8). However, only 59
subjects were studied, and most of the subjects were < 40 years of age, so the comparison of
slopes between ethnic/racial groups are only accurate up to 40 years of age.
Studies demonstrate that DLCO10s is lower by ~2 (~6%) and ~5 (~15%) mL/min/mmHg
in black, age and height matched males compared to matched white females, respectively [17],
due to mostly, differences in lung volumes between the two ethnic/racial groups. We also found
that the predicted DLNO in the male black population was 7% to 10% lower compared to the
predicted value for the age and height matched white male population. In the female black
population, DLNO was 12 to 15% compared to the predicted value for the age and height
matched white female population. And these differences was largely due to a 10% (male) to 15%
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(female) smaller predicted alveolar volume in blacks compared to whites. This shows that if a
prediction equation for DLNO for whites was used in a black population, there would be a
misdiagnosis of poor gas transfer in the lung in 12 to 15% of the black population, and that is
because of the lower alveolar volumes in blacks compared to sex, age, and height matched
whites. That’s why ethnic/racial specific equations must be made for DLNO.
In the future, it will be interesting to see the comparisons of DLNO prediction equations
with other racial/ethnic groups including mixed-race groups. As one can see, there there is a lot
of work that still needs to be done.
Limitations
We were only able to obtain data on 59 subjects due to several factors. First, there was great
difficulty in finding subjects ≥ 40 years of age. Second, the HYP’Air pulmonary function
system needed repair and thus we were not able to collect data for two months. However, we are
confident that the DLNO prediction equation works well in subjects < 40 years of age as ~80%
of the subjects were below 40 years of age.

Conclusion
The development of racially-adjusted prediction equations for DLNO can help prevent
misdiagnosis of lung disease. Racially-adjusted prediction equations for DLNO allows clinicians
to make a more accurate interpretation of a patient’s lung function which will lead to a better
diagnosis and management of lung illnesses. In this study, about 77% of the variance in DLNO
was accounted for by sex (67%), age2 (7%), and height (4%). Also, the prediction equations in
the black population yielded lower predicted DLNO, KNO, and VA compared to the prediction
equations developed for white subjects [22]. Black males had a 7-10% lower DLNO, and black
females had a 12-15% lower DLNO compared to matched white subjects. Black males of the
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same age and height had a 10% smaller alveolar volume, while black females had a 15% lower
alveolar volume compared to matched whites. Heart rate was negatively associated with DLNO
and DLCO. Finally, the regression model presented predicted DLNO in black subjects, but only
the model was only accurate in those below 40 years of age. The addition of older black subjects
to this model in the future will help make this prediction equation more useful.
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LIST OF TABLES
Table 1. DLNO5s prediction equations for white subjects.
Study

Adults (White
subjects)
van der Lee et al.
(2007)
(mmoL/min/kPa)
Females
van der Lee et al.
(2007)
(mmoL/min/kPa)
Males
Aguilaniu et al.
(2008)
(mL/min/mmHg)
>59 years old
Aguilaniu et al.
(2008)
(mL/min/mmHg)
≤ 59 years old
Zavorsky et al.
(2008)
(mL/min/mmHg)
Zavorsky et al.
(2017)
(mL/min/mmHg)
Children (white
subjects)
Thomas et al.
(2014)
(mmoL/min/kPa)

BHT Number
of
subjects

R2

SEE

0.5347· (height in cm) – 0.077·(age)
– 48.28

10s

59 F

--

5.22

0.5984· (height in cm) – 0.25·(age) –
44.20

10s

65 M

--

6.39

1.365· (height in cm) – 0.90 · (age) +
27.35·(Sex) – 54.69

4s

59 F
45 M

0.72

--

1.365· (height in cm) – 0.88 · (age) +
27.35·(Sex) – 54.69

4s

59 F
45 M

0.72

--

1.17· (height in cm) – 1.21 · (age) +
31.81·(Sex) – 20.1

5s

64 F
66 M

0.70

20.2

0.81· (height in cm) – 0.010·(age2) +
34.4 · (sex) + 9.7

6s

242 F
248 M

0.69

20.0

Exp [1.3145 + 0.0214·(age) –
0.0058·(sex) + 0.0119· (height in
cm) – 1.2893·10-8 · (height in cm)3 +
2.7070·10-8·(Sex) · (height in cm)3]

5s

312

--

Prediction equation for DLNO5s

--

BHT = breath-hold time (s); SEE = standard error of the estimate; Sex (1 = male, 0 = female).
Note: There were prediction equations developed by Rouatbi et al. (2010) for North-African
adults where DmCO and Vc were estimated based on DLCO and DLNO [32]. However, no
actual prediction equations for DLNO were found in that article. As such, Rouatbi’s paper using
for North-African adults is not included in this table.
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Table 2. DLCO5s prediction equations for white subjects.
Study

Adults (White)
van der lee et al.
(2007)
(mmoL/min/kPa)
Females
van der lee et al.
(2007)
(mmoL/min/kPa)
Males
Aguilaniu et al.
(2008)
(mL/min/mmHg)
>59 years old
Aguilaniu et al.
(2008)
(mL/min/mmHg)
≤ 59 years old
Zavorsky et al.
(2008)
(mL/min/mmHg)
Zavorsky et al.
(2017)
(mL/min/mmHg)
Children (white)
Thomas et al.
(2014)
(mmoL/min/kPa)

Prediction equation for DLCO5s

BHT Number
of
subjects

R2

SEE

10.51· (height in m) – 0.030·(age) –
7.43

10s

59 F

--

1.37

12.02· (height in m) – 0.074·(age) –
6.88

10s

65 M

--

1.74

29.291· (height in m) – 0.262 · (age)
+ 5.044·(Sex) – 12.954

4s

59 F
45 M

0.73 --

29.291· (height in m) – 0.161 · (age)
+ 5.044·(Sex) – 12.954

4s

59 F
45 M

0.73 --

0.214· (height in cm) – 0.242 · (age)
+ 5.94·(Sex) – 1.3

5s

64 F
66 M

0.69 4.0

0.23· (height in cm) – 0.002·(age2) +
6.0 · (sex) – 8.5

6s

242 F
248 M

0.68 4.2

Exp [0.9440 + 0.0205·(age) +
0.0908·(sex) + 1.6233·10-7 · (height
in cm)-3]

5s

312

--

--

BHT – breath-hold time (s); Sex (1 = male, 0 = female). Note: There were prediction equations
developed by Rouatbi et al. (2014) for North-African children where DmCO and Vc were
estimated based on DLCO and DLNO [34]. However, no actual prediction equations for DLNO
were found in that article. As such, Rouatbi’s paper using North African children is not included
in this table.
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Table 3. Anthropometric characteristics of the subjects including age.
Males (n = 27)
Age (years)

28 (10)
[18 to 55]

Females
(n = 32)
32 (14)
[20 to 67]

Weight (kg)

78.6 (11.1)
[61 to 102.4]

68.3 (13.9)
[47.8 to 95.7]

Height (cm)

176.2 (6.7)
[163.1 to 189.4]

163.2 (6.7)
[140.2 to 180.0]

73.0 (13.6)
[47.8 to
102.4]
169 (10)
[140 to 189]

Body mass index (kg/m2)

25.3 (2.9)
[18.8 to 30.6]

25.3 (4.4)
[17.2 to 32.3]

25.3 (3.8)
[17.2 to 32.3]

Waist Circumference (cm)

83.7 (8)
[66 to 100]
101.8 (6.9)
[90.5 to 119.0]

82.3 (11)
[65 to105]
102.5 (9.6)
[87.6 to 119.0]

82.9 (9.7)
[65 to 105]
102.2 (8.4)
[87.6 to 119]

0.82 (0.04)
[0.72 to 0.90]

0.80 (0.06)
[0.69 to 0.96]

0.81 (0.05)
[0.69 to 0.96]

Hip Circumference (cm)

WHR

Combined
(n = 59)
30 (12)
[18 to 67]

Mean (SD). Brackets represent the range. Body mass index (BMI) is calculated weight (Kg)
divided by height2 (meters).

Table 4. Spirometric results of the subjects.
Mean value

% predicted

p-value

SVC (L)

4.16 (0.94)

--

--

FVC (L)

4.20 (0.91)

111 (11)

0.000

FEV1 (L)

3.48 (0.72)

109 (13)

0.000

FEV1/FVC

0.83 (0.07)

98 (7)

0.014

TLC (L)

5.82 (1.24)

99 (11)

0.529

5 of 59 subjects (~8%) demonstrated a mild obstructive pattern based on being below the LLN
for FEV1/FVC. The % predicted for FVC, FEV1, and FEV1/FVC was from The Global Lung
Function Initiative prediction equations for blacks [36]. The % predicted TLC was from white
prediction equations from Verbanck and colleagues [3].
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Table 5. Pulmonary diffusing capacity results.
Males
Females
(n = 27)
(n = 32)
Hyp’Air (5 s BHT)
DLNO
(mL/min/mmHg)
DLCO
(mL/min/mmHg)
DMCO
(mL/min/mmHg)
Vc (mL)
VA(L)
DmCO/VA ratio
(mL/min/mmHg/L)
KCO(mL/min/mmHg/L)
KNO(mL/min/mmHg/L)
DLNO/DLCO ratio

165 (23)
[120 to 205]
32.9 (5.0)
[23.1 to 43.9]
169 (29)
[127 to 238]
73 (13)
[50 to 103]
6.2 (0.9)
[5.8 to 7.9]
27.4 (4.5)
[19.8 to 35.2]
5.3 (0.8)
[3.5 to 6.7]
26.7 (3.8)
[18.6 to 32.9]
5.0 (0.3)
[4.3 to 5.5]

110 (162)
[71 to 138]
21.4 (2.6)
[16.6 to 27.0]
107 (26)
[54 to 192]
52 (7)
[44 to 69]
4.5 (0.7)
[3.1 to 6.3]
23.8 (5.1)
[16.7 to 36.7]
4.8 (0.6)
[3.6 to 6.0]
24.6 (3.3)
[18.3 to 29.6]
5.1 (0.4)
[4.3 to 6.3]

Combined
(n = 59)

135 (34)
[71 to 205]
26.6 (7)
[16.6 to 43.9]
136 (42)
[54 to 238]
62 (14)
[44 to 103]
5.3 (1.2)
[3.1 to 7.9]
25.5 (5.1)
[16.7 to 36.7]
5.0(0.8)
[3.5 to 6.7]
25.5 (3.6)
[18.3 to 32.9]
5.1 (0.4)
[4.3 to 6.3]

Bodybox (10 s BHT)
32.6 (4.0)
[26.6 to 44.6]
6.0 (0.8)
[4.5 to 8.4]
5.5 (0.8)
KCO(mL/min/mmHg/L)
[3.4 to 7.4]
6.8 (1.0)
TLC (L)
[5.0 to 9.3]
Mean (SD). Brackets represent the range.

21.5 (2.3)
[16.4 to 26.8]
4.4 (0.7)
[3.1 to 5.9]
5.0 (0.8)
[3.4 to 6.8]
5.0 (0.7)
[4.0 to 7.0]

DLCO
(mL/min/mmHg)
VA (L)
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26.6 (6.4)
[16.4 to 44.6]
5.1 (1.1)
[3.1 to 8.4]
5.2 (0.8)
[3.4 to 7.4]
5.8 (1.2)
[4.0 to 9.3]

Table 6. Inhaled and exhaled gases including breath-hold time (BHT) for both PFT machines
(Hyp’Air and BodyBox).

Hyp’Air

BodyBox

O2
CO
He
NO
BHT
Inspire Expire Inspire Expire Inspire Expire Inspire Expire
19.7
16.8
0.30
0.10
9.5
6.0
43 (4) 4 (1.0) 5.6
(0.12) (0.54) (0.00) (0.02)
(0.6)
(0.6)
(0.6)
20.7
(2.4)

17.7
(0.6)

0.30
(0.01)

0.10
(0.01)

10
(0.1)

7.0
(0.6)

--

--

10.3
(0.5)

Mean (SD)

Table 7. The differences in DLCO between the two PFT systems using two different breath-hold
times.

VA (L)
DLCO (L)

BodyBox (10s BHT)
5.1 (1.1)
26.6 (6.4)

3.95 (0.86)
Inspired
volume (L)
Mean (SD). BHT = breath-hold time.

Hyp’Air (5s BHT)
5.3 (1.2)

∆
-0.15 (0.4)

P value
0.004

26.6 (7.0)

-0.1 (3.1)

0.868

3.72 (0.84)

0.24 (0.28)

0.000
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Table 8. Predictive equations for healthy black adults using a 5 s breath-hold (Hyp’Air PFT
system) for DLNO and DLCO, and 10 s breath-hold (Bodybox) for DLCO.
Height
(cm)

DLNO
(mL/min/mmHg)
DLCO
(mL/min/mmHg)
DMCO
(mL/min/mmHg)
Vc
(mL)
VA
(L)
Vc/VA
(mL/L)
DMCO/VA
(mL/min/mmHg/L)
KCO
(mL/min/mmHg/L)
KNO
(mL/min/mmHg/L)

Age2

Sex

Constant Adjusted
R2

SEE

LLN
and
ULN

Hyp’Air (5s BHT)
– 0.012
38.8
– 25.2

0.77

16.3

± 32.6

--

– 0.002

11.0

23.3

0.72

3.7

± 7.4

1.66

– 0.016

35.6

– 143.9

0.71

22.3

± 44.6

--

– 0.003

19.7

56.3

0.55

9.6

± 19.2

0.056

--

1.0

– 4.61

0.69

0.64

± 1.28

-0.11

– 0.001

1.32

30.3

0.26

1.7

± 3.4

1.32

– 0.04

--

6.9

0.41

4.0

±8

– 0.034

– 0.00033

0.87

10.8

0.51

0.6

± 1.2

--

– 0.00264

--

28.31

0.43

2.8

± 5.5

0.92

BodyBox (10s BHT)
--11.14
21.46
0.75
3.2
± 6.4
DLCO
(mL/min/mmHg)
0.06
-0.89
-5.41
0.72
0.59
± 1.18
VA (L)
-– 0.000394
-5.62
0.176
0.74
± 1.48
KCO
(mL/min/mmHg/L)
SEE = standard error of the estimate. Age is in years; height is in cm. Sex = 1 for males, 0 for
females.
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Table 9. Difference in predicted DLNO, KNO, and VA between blacks and whites of the same
age.

Whites
Blacks
Difference
% Difference

25 years of age and 175 cm tall
DLNO (males)
DLNO
(females)
180
145
167
128
13
17
7%
12%

45 years of age and 175 cm tall
DLNO (males)
DLNO
(females)
166
131
150
112
14
19
10%
15%

Whites
Blacks
Difference
% Difference

25 years of age and 175 cm tall
VA (males)
VA (females)
6.9
6.1
6.2
5.2
0.7
0.9
10%
15%

45 years of age and 175 cm tall
VA (males)
VA (females)
6.9
6.1
6.2
5.2
0.7
0.9
10%
15%

25 years of age and 175 cm tall
45 years of age and 175 cm tall
KNO (males)
KNO (females)
KNO (males)
KNO (females)
25.5
25.5
23.6
23.6
Whites
26.7
26.7
23.0
23.0
Blacks
1.2
1.2
0.6
0.6
Difference
5%
5%
3%
3%
% Difference
For blacks, the prediction equations used were from Table 8. For whites, the prediction equations
used were from the ERS Task Force document [22]. DLNO is measured in mL/min/mmHg, VA
is measured in L, and KNO is measured in ml/min/mmHg/L.
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LIST OF FIGURES
Figure 1. The association between resting heart rate (HR) and diffusing capacity.
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